Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Public Outreach Efforts On E-Prescribing Urged

This article was originally published in The Pink Sheet Daily

Executive Summary

Outreach efforts are needed to improve public understanding of e-prescribing, the National Committee on Vital & Health Statistics Privacy & Confidentiality Subcommittee said at a Nov. 18 meeting

You may also be interested in...



Roche Begins Search For Partner On Pipeline Products

Roche will need partners for its pipeline products, Head of Research Strategy Paul Nakagaki, PhD, said

E-Prescribing Pilot Tests Should Address Patient Opt-Out, Cmte. Says

National Committee on Vital & Health Statistics' Privacy & Confidentiality Subcommittee will suggest to the HHS Secretary in a March 2005 letter that e-prescribing pilots test patient ability to opt-out, as well as interstate operability.

Roche Begins Search For Partner On Pipeline Products

Roche will need partners for its pipeline products, Head of Research Strategy Paul Nakagaki, PhD, said

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058189

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel